Auto-Brewery Syndrome (ABS), also known as gut fermentation syndrome, is a unique and interesting condition. It has ignited curiosity throughout the field and beyond. Bernd Schnabl’s pioneering research reveals groundbreaking understanding of an uncommon malady. This rare condition allows the body to ferment sugar into alcohol, leading to increased BAC levels without even drinking alcoholic drinks.
The median age of patients detected in Schnabl’s cohort was 45 years with most patients being male. Curiously, these patients were mostly mildly overweight and had no features of liver disease. It is an insidious condition that few doctors understand. At present, there are no standardized diagnostic tests for ABS, creating challenges in identifying and managing ABS.
Understanding Auto-Brewery Syndrome
ABS results from the production of high levels of ethanol by the gut microbiota. This endogenous production can lead BAC to spike. They can go as high as 136 mg/dL in an episode, well over the legal driving limit in the United States. Understandably, this phenomenon raises alarm bells for patients. Or, without even knowing it, they may be getting themselves drunk through the action of their gut microorganisms.
Schnabl took this opportunity to emphasize the challenge in pinpointing ABS. As an example, he said, “The literature definitively says ABS is a rare disease, but I contend there are more patients with ABS; they’re just unaware of it.” I would guess a lot of them are having subclinical symptoms, brain fog, excessive fatigue.
Patients with ABS frequently describe debilitating cognitive dysfunctions such as brain fog and impaired focusing ability. Schnabl explained, “Patients really are obsessed with this brain fog; it affects their ability to read and focus, and it’s quite debilitating. This cognitive toll is a source of enormous hardship as individuals with the condition try to make their way through everyday life while awaiting a clear diagnosis.
Diagnosis and Testing Methods
As a special challenge, diagnosing ABS is complicated by the lack of a standardized available test. A research and clinical approach A clinical approach usually consists of standardized oral glucose tolerance challenge test. This clinical test is able to detect high ethanol levels in patients’ blood after glucose consumption.
Research indicates that patients with ABS produce ethanol levels comparable to or even exceeding those found in individuals who consume alcohol. During the glucose tolerance test, fecal samples from these patients have shown an overabundance of ethanol-generating gut microbiota. Schnabl walked us through this strange occurrence, reminiscing, “They all produced some very small yield of ethanol, which was really baffling to us at first.”
At the same time, too many patients have to fight to receive an accurate diagnosis. They frequently shop around between medical centers across the country, only to walk away still uninformed. Schnabl reflected on this challenge, saying, “They don’t get a firm diagnosis and go from one medical center to another, and they suffer from complications of alcohol use disorder including serious family, social, and legal problems.”
Treatment Options for Patients
Getting to know ABS has been an ongoing process. Therapies such as Fecal Microbiota Transplantation (FMT) hold immense potential for controlling the condition. Most important, some patients who had FMT treatment went into remission, pointing to the possibility that there are therapeutic interventions that can change gut microbiota composition to benefit health.
There’s a reminder in treating ABS that gut health is critical to overall wellness. It’s crucial to understand its role in the innumerable health conditions. Through the management of underlying microbiota imbalances, healthcare providers can better help patients thrive and live their best lives.
Leave a Reply